Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Justet (Paris , France), M. Hachem (Paris , France), T. Boghanim (Paris , France), M. Jaillet (Paris , France), L. Ling (San Francisco , United States of America), A. Mailleux (Paris , France), B. Crestani (Paris , France). FGF19, a potential innovative target in Idiopathic Pulmonary Fibrosis?. 2116

Member's Comments

No comment yet.

Related content which might interest you: Implication of FGFR4 and its ligands in Idiopathic Pulmonary Fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 Serum ST2 in Idiopathic Pulmonary Fibrosis (IPF): a possible new biomarker of disease? Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 FGFR4 has pro fibrotic properties in Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Evaluation of Idiopathic Pulmonary Fibrosis therapies, Pirfenidone and Nintedanib, in a Human Experimental Model of Fibrosis Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 IPF - Idiopathic Pulmonary Fibrosis Source: Breathe, 15 (2) 153; 10.1183/20734735.ELF152 Year: 2019 Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – M-health/e-health I Year: 2019 Impact of an interstitial lung diseases Nurse on the compliance to anti-fibrotic drugs in patients with Idiopathic Pulmonary Fibrosis. Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015 MiR-214-3p, a new fibromiR involved in the pathogenesis of idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 IGFBP-2 a new interesting target in IPF Source: International Congress 2016 – ILD pathogenesis Year: 2016 Impact of specific organic exposure on the prognosis in Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 What can we learn from Idiopathic Pulmonary Fibrosis Registries? Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 The role of Frizzled8 in idiopathic pulmonary fibrosis Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019 Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Courses: Interstitial Lung Diseases Year: 2019 Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 IPFdatabase – A new tool for a correct application of idiopathic pulmonary fibrosis guidelines Source: International Congress 2014 – ILDs 2 Year: 2014 Idiopathic Pulmonary Fibrosis behavior in the aged population- is it different? Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020